Open AccessClinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Author(s) -
Ф. У. Дзгоева,
О. В. Ремизов,
Victoria Kh. Botcieva,
V. G. Goloeva,
N. G. Malakhova,
Z. R. Ikoeva
Publication year - 2022
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.181
H-Index - 14
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.26442/00403660.2022.06.201562
Subject(s) - sclerostin , medicine , endocrinology , kidney disease , renal function , parathyroid hormone , osteoprotegerin , osteopontin , bone remodeling , kidney , calcification , biology , wnt signaling pathway , biochemistry , receptor , activator (genetics) , gene , calcium
To clarify the mechanisms of the effect of osteoprotegerin (OPG) and sclerostin on vascular calcification and the state of the cardiovascular system in chronic kidney disease (CKD).